Feng Chi Biotech Corp. (TPEX:6744)
Taiwan · Delayed Price · Currency is TWD 15.05
-0.20 (-1.31%)
Apr 1, 2026, 1:35 PM CST
Feng Chi Biotech Market Cap
Feng Chi Biotech has a market cap or net worth of 241.78 million as of April 1, 2026. Its market cap has decreased by -19.90% in one year.
Market Cap
241.78M
Enterprise Value
56.99M
Revenue
179.94M
Ranking
n/a
PE Ratio
15.55
Stock Price
15.05
Market Cap Chart
Since September 25, 2019, Feng Chi Biotech's market cap has decreased from 742.28M to 241.78M, a decrease of -67.43%. That is a compound annual growth rate of -15.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2026 | 234.85M | -14.33% |
| Dec 31, 2025 | 274.12M | -10.10% |
| Dec 30, 2024 | 304.92M | -10.81% |
| Dec 29, 2023 | 341.88M | 11.00% |
| Dec 29, 2022 | 308.00M | -19.19% |
| Dec 28, 2021 | 381.15M | -16.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Taiwan Advance Bio-Pharmaceutical | 922.50M |
| NatureWise Biotech & Medicals | 921.25M |
| TCI GENE | 915.46M |
| Neith | 899.73M |
| BioLASCO Taiwan | 747.87M |
| SynCore Biotechnology Co.,Ltd | 719.12M |
| TaiwanJ Pharmaceuticals | 602.52M |
| Vectorite Biomedical | 538.39M |